• Latest Posts

BioInnovation Institute supports three start-ups

Interview 17 Aug 2022

The challenges of developing radiopharmaceuticals for cancer

Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates

Glycostem and medac sign deal on AML and MM product

BioMed X Institute and Merck start new oncology research project

First of a kind multiple sclerosis biosimilar natalizumab accepted by US Food and Drug Association

ADVERTISEMENT

Consortium awarded €4M towards platform for personalized cell therapies

In Depth 13 Jul 2022

The biggest European biotech investments in June 2022

Legochem Bioscience signs agreement with Glycotope to develop cancer drug

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

Symrise Cosmetic Ingredients partners with evoxx technologies

Sirana Pharma and Pfizer to work on treatment for brittle bone disease

ADVERTISEMENT